Givinostat access: progress made and the work still to do
Translarna, a treatment for Duchenne muscular dystrophy, remains available in the UK
DMD Care UK webinar for patients and families about vamorolone
By ellen moye
Researchers develop a new approach for muscle gene therapies
Givinostat – why is accessing new treatments so difficult?
New drug for Duchenne muscular dystrophy to be made available in Scotland
By amber sunner
Duchenne muscular dystrophy treatment givinostat conditionally approved in the UK
Disappointing results from phase 2 clinical trial for Duchenne muscular dystrophy
NICE recommends new drug for Duchenne muscular dystrophy to be made available in England
By amber sunner
Early Access Programme for new Duchenne muscular dystrophy treatment givinostat
By ellen moye
Project secures funding to continue genotype phenotype correlation of the DMD and BMD brain
By amber sunner